Opioid therapy in the treatment of chronic pain conditions in Germany

Pain Physician

Volumn 18, Issue 3, 2015, Pages E323-E331

  Werber, Andreas ^a   Marschall, Ursula ^b   Lhoest, Helmut ^b   Hauser, Winfried ^c,d   Moradi, Babak ^a   Schiltenwolf, Marcus ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b BARMER Health Insurance   (Germany)

^c KLINIKUM SAARBRÜCKEN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chronic pain conditions; Opioid therapy

Indexed keywords

FENTANYL; HYDROMORPHONE; MORPHINE; NALOXONE; OPIATE; OXYCODONE; TILIDINE; TRAMADOL; NARCOTIC ANALGESIC AGENT;

ADULT; AGE; ARTICLE; CHRONIC PAIN; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DEFINED DAILY DOSE; FEMALE; GENDER; GERMANY; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MALE; MEDICAL SPECIALIST; OBSERVATIONAL STUDY; PHYSICIAN ATTITUDE; PRESCRIPTION; PSYCHOGENIC PAIN; TRANSDERMAL PATCH; TUMOR PAIN; AGED; ANALGESIA; ECONOMICS; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME;

ADULT; AGED; ANALGESICS, OPIOID; CHRONIC PAIN; FEMALE; FENTANYL; GERMANY; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; PAIN MANAGEMENT; TREATMENT OUTCOME;

EID: 84929471981     PISSN: 15333159     EISSN: 21501149     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Schubert I, Ihle P, Sabatowski R. Increase in opiate prescription in Germany between 2000 and 2010: A study based on insurance data. Dtsch Arztebl Int 2013; 110:45-51.
2. Zenz M, Zenz T, Tryba M, Strumpf M. Severe undertreatment of cancer pain: A 3-year survey of the German situation. J Pain Symptom Manage 1995; 10:187-191.
3. Robert-Koch-Institut. Chronische Schmerzen (Chronic Pain Disorder). Berlin, 2002. RKI, Berlin.
4. Ho KY, Chua NH, George JM, Yeo SN, Main NB, Choo CY, Tan JW, Tan KH, Ng BY. Evidence-based guidelines on the use of opioids in chronic non-cancer pain – a consensus statement by the Pain Association of Singapore Task Force. Ann Acad Med Singapore 2013; 42:138-152.
5. Koyyalagunta D, Bruera E, Solanki DR, Nouri KH, Burton AW, Toro MP, Bruel BM, Manchikanti L. A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician 2012; 15:ES39-ES58.
6. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, Burton AW, Calodney AK, Caraway DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator I, Falco FJ, Fellows B, Geffert S, Gharibo CG, Glaser SE, Grider JS, Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm S, 2nd, Hirsch JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla Y, Manchikanti KN, McManus CD, Pampati V, Parr AT, Pasupuleti R, Patel VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solanki DR, Tracy DH, Vallejo R, Wargo BW. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I – evidence assessment. Pain Physician 2012; 15:S1-S65.
7. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, Burton AW, Calodney AK, Caraway DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator I, Falco FJ, Fellows B, Geffert S, Gharibo CG, Glaser SE, Grider JS, Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm S, 2nd, Hirsch JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla Y, Manchikanti KN, McManus CD, Pampati V, Parr AT, Pasupuleti R, Patel VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solanki DR, Tracy DH, Vallejo R, Wargo BW. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2 – guidance. Pain Physician 2012; 15:S67-S116.
8. Manchikanti L, Vallejo R, Manchikanti KN, Benyamin RM, Datta S, Christo PJ. Effectiveness of long-term opioid therapy for chronic non-cancer pain. Pain Physician 2011; 14:E133-E156.
9. Sorgatz H, Hege-Scheuing G, Kopf A, Maier C, Sabatowski R, Schafer M, Stein C, Tolle TR, Willweber-Strumpf A. [Consensus building on “Long-term opioid administration and non-tumor pain”]. Z Arztl Fortbild Qualitatssich 2002; 96:317-323.
10. Martell BA, O’Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med 2007; 146:116-127.
11. Ashworth J, Green DJ, Dunn KM, Jordan KP. Opioid use among low back pain patients in primary care: Is opioid prescription associated with disability at 6-month follow-up? Pain 2013; 154:1038-1044.
12. Schwarzer A, Maier C. [Opiates in the treatment of non-cancer-related pain]. MMW Fortschr Med 2011; 153:51-53.
13. Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, Fine PG, Foley KM, Gallagher RM, Gilson AM, Haddox JD, Horn SD, Inturrisi CE, Jick SS, Lipman AG, Loeser JD, Noble M, Porter L, Rowbotham MC, Schoelles KM, Turk DC, Volinn E, Von Korff MR, Webster LR, Weisner CM. Opioid pharmacotherapy for chronic non-cancer pain in the United States: A research guideline for developing an evidence-base. J Pain 2010; 11:807-829.
14. WHO. Cancer Pain Relief. World Health Organization Publications, Geneva, 1986.
15. WHOCC. DDD Definition and general considerations, in - CCfDSM (ed). www.whocc.no/ddd/definition_and_general_considera/.
16. Reinecke H, Sorgatz H. [S3 guideline LONTS. Long-term administration of opioids for non-tumor pain]. Schmerz 2009; 23:440-447.
17. Lindena G, Hildebrandt J, Diener HC, Schops P, Maier C. [Pain treatment facilities in Germany. Ambulatory, day care and inpatient facilities for patients with chronic pain]. Schmerz 2004; 18:10-16.
18. Breiman L. CART: Classification and Regression Trees. Crc Pr Inc., 1984.
19. Freytag A, Schiffhorst G, Thoma R, Strick K, Gries C, Becker A, Treede RD, Muller- Schwefe G, Casser HR, Luley C, Hoer A, Ujeyl M, Gothe H, Kugler J, Glaeske G, Haussler B. [Identification and grouping of pain patients according to claims data]. Schmerz 2010; 24:12-22.
20. Nilges P, Rief W. [F45.41: Chronic pain disorder with somatic and psychological factors: A coding aid]. Schmerz 2010; 24:209-212.
21. Fredheim OM, Skurtveit S, Breivik H, Borchgrevink PC. Increasing use of opioids from 2004 to 2007 – pharmacoepidemiological data from a complete national prescription database in Norway. Eur J Pain 2010; 14:289-294.
22. Manchikanti L, Ailinani H, Koyyalagunta D, Datta S, Singh V, Eriator I, Sehgal N, Shah R, Benyamin R, Vallejo R, Fellows B, Christo PJ. A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician 2011; 14:91-121.
23. Kahan M, Mailis-Gagnon A, Tunks E. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Implications for pain physicians. Pain Res Manag 2011; 16:157-158.
24. Logan J, Liu Y, Paulozzi L, Zhang K, Jones C. Opioid prescribing in emergency departments: The prevalence of potentially inappropriate prescribing and misuse. Med Care 2013; 51:646-653.
25. Breivik H. Opioids in chronic non-cancer pain, indications and controversies. Eur J Pain 2005; 9:127-130.
26. Rief W, Zenz M, Schweiger U, Ruddel H, Henningsen P, Nilges P. Redefining (somatoform) pain disorder in ICD-10: A compromise of different interest groups in Germany. Curr Opin Psychiatry 2008; 21:178-181.
27. Ponizovsky AM, Marom E, Zeldin A, Cherny NI. Trends in opioid analgesics consumption, Israel, 2000-2008. Eur J Clin Pharmacol 2011; 67:165-168.
28. Garcia del Pozo J, Carvajal A, Viloria JM, Velasco A, Garcia del Pozo V. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol 2008; 64:411-415.
29. Pflughaupt M, Scharnagel R, Gossrau G, Kaiser U, Koch T, Sabatowski R. [Physicians’ knowledge and attitudes concerning the use of opioids in the treatment of chronic cancer and non-cancer pain]. Schmerz 2010; 24:267-275.
30. Akd Ä. Die unkritische Anwendung von Fentanylpflastern erhöht das Risiko für schwerwiegende Nebenwirkungen. Dtsch Arztebl 2012; 109.
31. Radbruch L, Sabatowski R, Petzke F, Brunsch-Radbruch A, Grond S, Lehmann KA. Transdermal fentanyl for the management of cancer pain: A survey of 1005 patients. Palliat Med 2001; 15:309-321.